PALIPERIDONE

USDailyMed:Paliperidone AU:B3 N05AX13(WHO) AU:S4(Prescription only)BR:Class C1(Other controlled substances)CA:℞-onlyUS:℞-onlyEU:Rx-only (RS)-3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one 144598-75-4Yas palmitate:199739-10-1 115237as palmitate:9852746 DB01267Yas palmitate:DBSALT001464 7978307Yas palmitate:8028457 838F01T721as palmitate:R8P8USM8FR D05339Yas palmitate:D05340 CHEBI:82978Nas palmitate:CHEBI:83807 ChEMBL1621Nas palmitate:ChEMBL2107360 Interactive im‍​‍‍‍​‍‍‍‍‍‍‍‍​‍age O=C/1N5/C(=N\C(=C\1CCN4CCC(c3noc2cc(F)ccc23)CC4)C)[C@H](O)CCC5 InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3/t19-/m1/s1YKey:PMXMIIMHBWHSKN-LJQANCHMSA-NYas palmitate: InChI=1S/C39H57FN4O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18-36(45)47-34-17-16-24-44-38(34)41-29(2)32(39(44)46)23-27-43-25-21-30(22-26-43)37-33-20-19-31(40)28-35(33)48-42-37/h19-20,28,30,34H,3-18,21-27H2,1-2H3Key:VOMKSBFLAZZBOW-UHFFFAOYSA-N Paliperidone, sold under the brand nameInvegaamong others, is anatypical antipsychotic.It is used for the treatment ofschizophreniaandschizoaffective disorder.It is marketed byJanssen Pharmaceuticals. Paliperidone was approved by the USFood and Drug Administration(FDA) for the treatment of schizophrenia in December 2006,and in the European Union in June 2007.Paliperidone palmitate is a long-acting injectable formulation of paliperidonepalmitoylester.It is on theWorld Health Organization's List of Essential Medicines.Paliperidone is available as ageneric medication.